Morphosys (MOR) has released an update.
MorphoSys AG has announced a change in their major holdings, revealing that Morgan Stanley now possesses a combined total of 10.68% of voting rights following a recent transaction. This shift occurred on April 15, 2024, with Morgan Stanley acquiring both direct voting shares and additional voting rights through financial instruments like equity swaps and options. The financial community is keenly observing these developments, which reflect significant changes in the ownership structure of MorphoSys.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
